Assessment of agreement of two high sensitivity troponin assays during an institutional transition

Abstract

Aim: During a recent institutional transition between two high sensitivity troponin assays, we sought to evaluate the correlation and agreement in an unselected population presenting to the ED undergoing troponin measurement.

Methods: This was a prospective study of consecutive patients presenting to a single, academic institution that underwent troponin testing. Paired samples of two high sensitivity troponin assays, hs-cTnT (Gen 5 TnT; Roche Diagnostics, Indianapolis, IN) and hs-cTnI (High Sensitive Troponin I Architect i2000; Abbott, Abbott Park, Illinois) were assessed for overall correlation and agreement. We also evaluated the paired difference between the two assays stratified by gender and CKD stage. Further, we determined reclassification at the 99th percentile limit and the institutional established abnormal.

Results: A total of 1349 unique patient encounters were included in the study with median result value of 12.2 ng/L (IQR 6-29.5) for hs-cTnT and 4.7 ng/L (IQR 3.5-15.5) for hs-cTnI. Direct comparison of the two assays indicated a Spearman Rho of 0.79 with poor agreement especially when cTn results were elevated. Paired difference was smaller in women with a difference of medians of 0.9 ng/L (0.06-1.67, P < 0.01) and three significant clusters (CKD 1, CKD 2 and 3, CKD 4 and 5; P < 0.01) were found when stratifying by Chronic Kidney Disease stage Reclassification occurred in 276 patients when evaluated at the 99th percentile and 148 patients at the institution’s abnormal cut-off.

Conclusion: There was moderate correlation seen during our transition between the two high sensitivity troponins, but differential bias with lower hs-cTnI than hs-cTnT at low levels and higher hs-cTnI than hs-cTnT at high values. Without the appropriate system level recommendations and established diagnostic protocol this level of disagreement can potentially cause problems with interpretation to the end clinician who has become accustomed to a specific assay’s thresholds.

Keywords

High sensitivity troponin / emergency medicine

References

[1] Levy PD.Evaluating suspected acute MI in the emergency department: what is and what should never be.J Am Coll Cardiol2019;74:495-7

[2] Kimenai DM,van der Kallen CJ.Direct comparison of clinical decision limits for cardiac troponin T and I.Heart2016;102:610-6

[3] Giannitsis E,Zeller T.Gender-specific reference values for high-sensitivity cardiac troponin T and I in well-phenotyped healthy individuals and validity of high-sensitivity assay designation.Clin Biochem2020;78:18-24

[4] Apple FS,Sandoval Y.Sex-specific 99th percentile upper reference limits for high sensitivity cardiac troponin assays derived using a universal sample bank.Clin Chem2020;66:434-44

[5] Lippi G,Aloe R,Salvagno GL.Non-commutability of results of highly sensitive troponin I and T immunoassays.Biochem Med (Zagreb)2012;22:127-9 PMCID:PMC4062322

[6] van der Linden N,Twerenbold R.Combining high-sensitivity cardiac troponin I and cardiac troponin T in the early diagnosis of acute myocardial infarction.Circulation2018;138:989-99

[7] Willett DL,Chu L.SNOMED CT concept hierarchies for sharing definitions of clinical conditions using electronic health record data.Appl Clin Inform2018;9:667-82 PMCID:PMC6115233

[8] Levey AS,Lewis JB,Rogers N.A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.Ann Intern Med1999;130:461-70

[9] Euser AM,le Cessie S.A practical approach to Bland-Altman plots and variation coefficients for log transformed variables.J Clin Epidemiol2008;61:978-82

[10] Bland JM.Statistical methods for assessing agreement between two methods of clinical measurement.Lancet1986;1:307-10

[11] Kimenai DM,Kooman JP.Troponin I and T in relation to cardiac injury detected with electrocardiography in a population-based cohort - The Maastricht Study.Sci Rep2017;7:6610 PMCID:PMC5529453

[12] Ungerer JPJ,Pretorius CJ.Discordance with 3 cardiac troponin I and T assays: implications for the 99th percentile cutoff.Clin Chem2016;62:1106-14

[13] Freda BJ,Van Lente F,Francis GS.Cardiac troponins in renal insufficiency: review and clinical implications.J Am Coll Cardiol2002;40:2065-71

[14] Artunc F,Breidthardt T.Sensitive troponins--which suits better for hemodialysis patients?.PLoS One2012;7:e47610 PMCID:PMC3471860

[15] Twerenbold R,Jaeger C.Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction.Circulation2015;131:2041-50 PMCID:PMC4456169

[16] Jaffe AS,Milone M,Olson KN.Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T.J Am Coll Cardiol2011;58:1819-24

[17] Rubini Gimenez M,Reichlin T.Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction.Eur Heart J2014;35:2303-11